SCHEMBL3847007

SCHEMBL3847007

Cc1ccn(-c2ncnc3ccc(Br)cc23)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 11/20 0.53
ALDH1A1 P00352 4/20 0.50
NPSR1 Q6W5P4 2/20 0.50
LMNA P02545 8/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
MAPK1 P28482 2/20 0.44
HPGD P15428 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
PIK3CD O00329 1/20 0.41
PIK3R1 P27986 1/20 0.41
HIF1A Q16665 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.40
NCOA1 Q15788 2/20 0.39
NCOA3 Q9Y6Q9 2/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845934 0.76 HTT (0.52) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL3846807 0.74 HTT (0.53) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL8021772 0.71 HTT (0.57) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL22715242 0.70 HTT (0.76) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL29472072 0.70 HTT (0.76) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL4349956 0.70 HTT (1.00) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL3115181 0.69 HTT (0.74) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL4351530 0.69 HTT (0.71) HTTALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL10637052 0.68 GAA (0.44) ALDH1A1NPSR1LMNAMEN1KMT2A
SCHEMBL16555262 0.67 RAB9A (0.53) HTTALDH1A1LMNASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed